# Australia's Monash IVF has turned down a takeover offer from a consortium valuing the fertility service provider at A$350.7 million.

*biotech · news · 2026-04-20 · Devdiscourse*

## Key points

- Monash IVF rejected a A$350.7 million takeover bid from a consortium including Genesis Capital.
- President Trump ordered the FDA to expedite review of psychedelic drugs like ibogaine for medical use.
- Rat poison contamination was found in HiPP baby food at 1,500 Austrian SPAR supermarkets, triggering a recall.
- Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for over $2 billion, with milestone payments possible.

**Companies:** Eli Lilly, Monash IVF, Washington H. Soul Pattinson, Genesis Capital, Kelonia Therapeutics
**Countries:** Australia, United States, Austria

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/health/3880092-global-health-highlights-corporate-moves-psychedelic-progress-and-product-safety-alerts)

---

Canonical: https://newsio.io/n/29c500fa-1ae7-495d-9bcd-df4c5d58e2e4/australias-monash-ivf-has-turned-down-a-takeover-offer-from-a-consortium-valuing
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works